Abridge vs DeepScribe (2026)
Scope against specialty. Abridge sells to health systems across outpatient, inpatient and emergency care, was named Best in KLAS for Ambient AI in 2025 and 2026, has a Kaiser Permanente evaluation published in NEJM AI, embeds natively in Epic across Haiku, Canto and Hyperdrive, and ties every sentence of a note to the source audio through Linked Evidence. DeepScribe went deep instead of wide, with oncology at the center, integrations into Epic, OncoEMR and iKnowMed, AI Coding for E/M, ICD-10 and HCC, and a 98.8 KLAS Spotlight score and a 2025 Journal of Clinical Pathways study behind it. If your failure mode is a system wide rollout across settings that compliance has to audit, start with Abridge. If it is complex specialty documentation that generalist scribes get wrong, oncology above all, start with DeepScribe. Neither publishes a price.
- Kaiser Permanente's evaluation of Abridge is published as peer reviewed research in NEJM AI, and by Abridge's account it tested the platform across more than 1,000 clinicians over six months before an enterprise rollout.
- Linked Evidence maps every part of a generated note back to the source audio, so a clinician can check any sentence against what was said before signing.
- Setting breadth is built in, with use across outpatient, inpatient and emergency care in more than 40 specialties and native Epic embedding that extends into structured orders and real time prior authorization.
- The oncology work is concrete, with integrations into OncoEMR and iKnowMed, a Flatiron partnership covering more than 4,200 providers, and SmartPrep for oncology pre visit preparation.
- KLAS scored DeepScribe 98.8 in its 2025 Spotlight report, with 15 A plus marks, and an August 2025 Journal of Clinical Pathways study reported 16 percent more diagnoses captured per visit in oncology.
- Coding lives in the note, with E/M, ICD-10 and HCC suggestions in the draft, and two way integrations into athenahealth and NextGen described in DeepScribe's own guides.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Abridge and DeepScribe are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Abridge | DeepScribe |
|---|---|---|
| Primary category | Ambient Scribes | Ambient Scribes |
| Founded | 2018 | 2017 |
| Headquarters | Pittsburgh, Pennsylvania | San Francisco, California |
| Website | abridge.com | deepscribe.ai |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Abridge is an enterprise ambient AI platform that turns the clinician patient conversation into a structured, billable note inside the EHR, sold to health systems rather than to individual clinicians. It partners with more than 300 health systems, including Kaiser Permanente, Mayo Clinic, Johns Hopkins, Duke Health, Memorial Sloan Kettering, Northwell, UPMC, Sutter Health and NYU Langone, and won the KLAS Research award for Ambient AI in 2025 and 2026.
Source: AI Health Index, July 2026
DeepScribe sells ambient AI documentation built for specialty care, with oncology at its center, to health systems, oncology networks and specialty groups. The scribe listens to the visit, pulls prior notes, labs, imaging, medications and diagnoses forward from the chart, and writes a structured note with coding suggestions back into the EHR.
Source: AI Health Index, July 2026
Questions buyers ask
How do Abridge and DeepScribe work with the EHR?
For Abridge, the integration is embedded in Epic Haiku and Hyperdrive, so recording, review and the finished note stay in the Epic workflow with no copy and paste step and no parallel interface. The February 2024 Epic announcement described the path as running from recording conversations in Haiku to embedding generated notes in the patient chart in Hyperdrive.
In Epic, including Haiku and Canto, a clinician picks the patient from a synced schedule, DeepScribe pulls prior context into the note, and the finished note and coding suggestions sync back in seconds. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
How are Abridge and DeepScribe priced and sold?
Abridge reaches its 300+ health systems through institutional contracts rather than individual clinician signup, and there is no self serve path. The trust center lists a master services agreement among its legal documents, held behind an access request alongside the security documentation.
DeepScribe's site offers a demo request and a sign in, its terms place fees, usage limits and other commercial terms in each order form, and it lists no rate, tier, unit of charge or trial. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
How do Abridge and DeepScribe handle patient data?
With Abridge, the OpenAI listing indicates that content derived from the encounter reaches a third party model provider.
The business associate agreement governs protected health information, and DeepScribe describes encryption in transit and at rest, role based access, multifactor authentication and de identification of patient data, with a HIPAA audit report listed in its trust center. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
Which settings and specialties do Abridge and DeepScribe cover?
The clinicians platform page says Abridge is used at over 40 specialties, with a structured, specialty specific note produced for each visit.
With DeepScribe, the company says it is used across 90 percent of community oncology centers, partners with Flatiron's network of more than 4,200 providers, integrates with OncoEMR and iKnowMed, and sells SmartPrep as an oncology pre visit product. It also publishes pages for cardiology, gastroenterology, neurology, orthopedics and urology, and a partnership with Pearl Health takes it to value based care providers. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers.
Deployment counts and market share figures for both vendors are vendor published, including Abridge's more than 300 health systems and DeepScribe's 90 percent of community oncology centers. The KLAS instruments differ, with Best in KLAS category awards for Abridge and the Spotlight report for DeepScribe.
An earlier version of this comparison said Abridge supports more than 28 languages, a figure that describes a customer's patient population rather than the platform, and quoted third party price estimates for DeepScribe that trace to no named source. Both were corrected on 10 October 2026.